温阳通络方基于miR-26b-3p调控类风湿关节炎滑膜成纤维细胞的机制研究
投稿时间:2024-02-29     点此下载全文
引用本文:李冬艳,田亚丹,宋佳欣,罗定霞,吴晶金.温阳通络方基于miR-26b-3p调控类风湿关节炎滑膜成纤维细胞的机制研究[J].中国现代中药,2024,26(10):1719-1726
DOI:10.13313/j.issn.1673-4890.20240229001
摘要点击次数: 44
全文下载次数: 0
              
作者中文名作者英文名单位中文名单位英文名E-Mail
李冬艳 LI Dong-yan 云南中医药大学 第一临床医学院,云南 昆明 650011 The First Clinical Medical College of Yunnan University of Traditional Chinese Medicine, Kunming 650011, China  
田亚丹 TIAN Ya-dan 云南中医药大学 第一临床医学院,云南 昆明 650011 The First Clinical Medical College of Yunnan University of Traditional Chinese Medicine, Kunming 650011, China  
宋佳欣 SONG Jia-xin 云南中医药大学 第一临床医学院,云南 昆明 650011 The First Clinical Medical College of Yunnan University of Traditional Chinese Medicine, Kunming 650011, China  
罗定霞 LUO Ding-xia 云南中医药大学 第一临床医学院,云南 昆明 650011 The First Clinical Medical College of Yunnan University of Traditional Chinese Medicine, Kunming 650011, China  
吴晶金* WU Jing-jin 云南省中医医院 风湿科,云南 昆明 650021 Department of Rheumatology, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming 650021, China  
基金项目:国家自然科学基金项目(82360924);云南省中医联合专项重点项目(202101AZ070001-161);兴滇英才“青年人才”项目;云南省高层次中医痹病学后备人才项目
中文摘要:目的 探讨温阳通络方基于微小RNA(miR)-26b-3p调控类风湿关节炎滑膜成纤维细胞增殖、迁移、侵袭的作用。方法 SD大鼠随机分为温阳通络方组和空白血清组。温阳通络方组大鼠给药剂量为4.05 g·kg–1·d–1,2次/d,间隔12 h,连续给药3 d,末次给药后1 h腹主动脉取血分离血清;细胞计数试剂盒-8(CCK-8)实验筛选温阳通络方含药血清最佳浓度和干预时间;在人类风湿关节炎滑膜成纤维细胞MH7A中分别转染inhibitor NC、miR-26b-3p inhibitor、mimic NC、miR-26b-3p mimic片段,并用温阳通络方含药血清干预,设置正常关节成纤维样滑膜细胞为对照组,实时定量聚合酶链式反应(qRT-PCR)检测MH7A细胞中miR-26b-3p的表达;CCK-8实验检测各组细胞的增殖情况;Transwell实验检测各组细胞的迁移、侵袭情况。结果 不同浓度温阳通络方含药血清均能上调miR-26b-3p的表达(P<0.05),miR-26b-3p的表达呈浓度依赖性升高。温阳通络方含药血清干预MH7A细胞后,细胞的增殖、迁移、侵袭能力减弱(P<0.05)。miR-26b-3p过表达后,MH7A细胞的增殖、迁移、侵袭能力减弱(P<0.05);干扰miR-26b-3p的表达后,MH7A细胞的增殖、迁移、侵袭能力增强(P<0.05)。在干扰miR-26b-3p表达的基础上,温阳通络方含药血清干预MH7A细胞后,细胞的增殖、迁移、侵袭能力减弱(P<0.05)。结论 温阳通络方通过上调miR-26b-3p的表达抑制类风湿关节炎滑膜成纤维细胞的增殖、迁移、侵袭。
中文关键词:类风湿关节炎  微小RNA-26b-3p  温阳通络方  滑膜成纤维细胞
 
Mechanism of Wenyang Tongluo Prescription in Regulating Synovial Fibroblasts in Rheumatoid Arthritis Based on MiR-26b-3p
Abstract:Objective To investigate the regulatory effect of Wenyang Tongluo Prescription on the proliferation, migration, and invasion of synovial fibroblasts in rheumatoid arthritis based on miR-26b-3p.Methods SD rats were randomly divided into a Wenyang Tongluo Prescription group and a blank serum group. The Wenyang Tongluo Prescription group was given Wenyang Tongluo Prescription at 4.05 g·kg–1·d–1, twice daily, with a 12-hour interval, for 3 consecutive days. Blood was collected from the abdominal aorta 1 hour after the last administration, followed by serum isolation. The Cell Counting Kit-8 (CCK-8) assay was used to determine the optimal concentration and intervention time of Wenyang Tongluo Prescription-containing serum. Human rheumatoid arthritis synovial fibroblasts (MH7A) were transfected with inhibitor NC, miR-26b-3p inhibitor, mimic NC, and miR-26b-3p mimic, respectively, and treated with Wenyang Tongluo Prescription-containing serum. Human fibroblast-like synovial cells (HFLS) were set as the blank control group. Real-time quantitative PCR (qRT-PCR) was used to detect the expression of miR-26b-3p in MH7A cells. The proliferation of cells in each group was detected by the CCK-8 assay. The migration and invasion of cells in each group were detected by the Transwell assay.Results The expression of miR-26b-3p was upregulated by serum containing Wenyang Tongluo Prescription at different concentrations (P<0.05), and the expression of miR-26b-3p increased in a concentration-dependent manner. After the intervention with the drug-containing serum of Wenyang Tongluo Prescription, the proliferation, migration, and invasion abilities of MH7A cells were weakened (P<0.05). After miR-26b-3p overexpression, the proliferation, migration, and invasion of MH7A cells were weakened (P<0.05). After interfering with the expression of miR-26b-3p, the proliferation, migration, and invasion of MH7A cells were enhanced (P<0.05). On the basis of interfering with the expression of miR-26b-3p, the proliferation, migration, and invasion of MH7A cells were weakened after intervention with the drug-containing serum of Wenyang Tongluo Prescription (P<0.05).Conclusion Wenyang Tongluo Prescription can inhibit the proliferation, migration, and invasion of synovial fibroblasts in rheumatoid arthritis by upregulating the expression of miR-26b-3p.
keywords:rheumatoid arthritis  miR-26b-3p  Wenyang Tongluo Prescription  synovial fibroblasts
查看全文   查看/发表评论  下载PDF阅读器